Core Insights - Zyn, a nicotine pouch brand, has rapidly gained popularity in the U.S., benefiting Philip Morris International amid a long-term decline in cigarette smoking [1][3] - The FDA has authorized 20 Zyn products for marketing in the U.S., citing lower health risks compared to traditional cigarettes and most smokeless tobacco products [2] - Zyn's growth aligns with Philip Morris's strategy to shift towards smokeless products, aiming for two-thirds of revenue to come from smoke-free sources by 2030 [4] Company Developments - In 2022, Philip Morris International acquired Swedish Match, the manufacturer of Zyn, for 600 million investment to build a new Zyn production facility in Aurora, Colorado, followed by an additional $232 million investment to expand production in Owensboro, Kentucky [5]
How Zyn helped Philip Morris International make a comeback